TET2 and T-cell acute lymphoblastic leukemia: Interestingly, AzaC treatment also restores TET2 expression and hmdC in a different leukemic context (T-cell acute lymphoblastic leukemia), which results in rapid cell death [41], suggesting that TET activity is an important factor for the efficiency of AzaC or AzadC treatment in inducing cell death.